We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+22.8%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$2.23B
AUM Growth
+$301M
Cap. Flow
-$59.4M
Cap. Flow %
-2.66%
Top 10 Hldgs %
83.23%
Holding
40
New
1
Increased
3
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
ARDX icon
Ardelyx
ARDX
+$24M
2
KA
Kineta, Inc. Common Stock
KA
+$6.13M
3
XCOM
XTERA COMMUNICATIONS INC COM STK (DE)
XCOM
+$3.27M
4
OREX
Orexigen Therapeutics, Inc.
OREX
+$1.26M

Top Sells

Rank Stock Value
1
GRPN icon
Groupon
GRPN
+$63.5M
2
EXEL icon
Exelixis
EXEL
+$17.2M
3
LOXO
Loxo Oncology, Inc
LOXO
+$13.2M
4
ZSAN
Zosano Pharma Corporation
ZSAN
+$120K

Sector Composition

Rank Sector Weight
1 Healthcare 84.35%
2 Communication Services 4.64%
3 Technology 1.52%
4 Consumer Discretionary 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSRO
1
DELISTED
TESARO, Inc.
TSRO
$1.03B 46.23%
10,275,113
– –
ARDX icon
2
Ardelyx
ARDX
$1.23B
$182M 8.18%
14,083,582
+2,290,951
+19% +$24M
DERM
3
DELISTED
Dermira, Inc.
DERM
$119M 5.35%
3,506,649
– –
GRPN icon
4
Groupon
GRPN
$1.05B
$103M 4.64%
1,003,788
-651,707
-39% -$63.5M
SENS icon
5
Senseonics Holdings Inc
SENS
$254M
$103M 4.6%
1,315,159
– –
ADAP
6
DELISTED
Adaptimmune Therapeutics
ADAP
$69.7M 3.13%
9,880,999
– –
NVRO
7
DELISTED
NEVRO CORP.
NVRO
$68.9M 3.09%
660,428
– –
EPZM
8
DELISTED
Epizyme, Inc
EPZM
$61.6M 2.77%
6,260,851
– –
CBIO
9
Crescent Biopharma
CBIO
$598M
$61.4M 2.75%
85,841
– –
KA
10
DELISTED
Kineta, Inc. Common Stock
KA
$55.5M 2.49%
25,406
+3,297
+15% +$6.13M
LXRX icon
11
Lexicon Pharmaceuticals
LXRX
$1.03B
$43M 1.93%
2,382,286
– –
CLVS
12
DELISTED
Clovis Oncology, Inc.
CLVS
$41.1M 1.84%
1,139,890
– –
LOXO
13
DELISTED
Loxo Oncology, Inc
LOXO
$33.8M 1.52%
1,289,420
-502,787
-28% -$13.2M
CRCM
14
DELISTED
CARE.COM, INC.
CRCM
$32.5M 1.46%
3,260,989
– –
ELGX
15
DELISTED
Endologix Inc
ELGX
$31.9M 1.43%
249,020
– –
HIVE
16
DELISTED
Aerohive Networks
HIVE
$28.5M 1.28%
4,681,455
– –
TRVN
17
DELISTED
Trevena, Inc.
TRVN
$25.7M 1.15%
6,099
– –
AKAO
18
DELISTED
Achaogen Inc
AKAO
$22.6M 1.01%
4,715,128
– –
CASC
19
DELISTED
Cascadian Therapeutics, Inc.
CASC
$17.6M 0.79%
1,791,667
– –
TCON
20
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$12.6M 0.57%
9,448
– –
RIGL icon
21
Rigel Pharmaceuticals
RIGL
$708M
$11.9M 0.53%
324,315
– –
SBBP
22
DELISTED
Strongbridge Biopharma plc.
SBBP
$11.2M 0.5%
2,141,308
– –
AVEO
23
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$9.22M 0.41%
1,036,269
– –
AUPH icon
24
Aurinia Pharmaceuticals
AUPH
$1.92B
$7.67M 0.34%
2,546,843
– –
SYBX
25
DELISTED
Synlogic
SYBX
$5.86M 0.26%
28,332
– –
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.76B AUM 13.06% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return

NEA Management Company's Q3 2016 Portfolio in Review

As of Q3 2016, NEA Management Company held 40 positions worth $2.23B, up 16% from $1.93B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

NEA Management Company's Q3 2016 filing shows 1 new, 3 increased, 3 reduced and 1 closed positions. Its largest new stake was XTERA COMMUNICATIONS INC COM STK (DE): 3,631,537 shares worth $2M. The largest sale was Groupon, an estimated $63.5M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 83% a quarter earlier, followed by Communication Services and Technology.

  • NEA Management Company's largest Q3 2016 buy was XTERA COMMUNICATIONS INC COM STK (DE): 3,631,537 shares worth $2M.
  • NEA Management Company added most to Ardelyx in Q3 2016, an estimated $24M increase.
  • NEA Management Company's biggest Q3 2016 reduction was Groupon, cutting an estimated $63.5M.
  • NEA Management Company fully exited Exelixis in Q3 2016, selling an estimated $17.2M.
  • NEA Management Company's ten largest holdings make up 83% of its $2.23B portfolio in Q3 2016.
  • NEA Management Company opened 1 new position and closed 1 in Q3 2016.
  • NEA Management Company's portfolio value rose 16% quarter-over-quarter to $2.23B.

Based on NEA Management Company's 13F filing for Q3 2016, filed 10 Nov 2016.